ASHP Member Testifies on Implications of Intravenous Immune Globulin Shortage
ASHP member Douglas Scheckelhoff, MS, RPh, testified on May 7, 1998, before the Subcommittee on Human Resources of the House Government Reform and Oversight Committee. Mr. Scheckelhoff is Director of Pharmacy at Children's National Medical Center, Washington, DC and appeared on behalf of his institution. The Subcommittee is investigating the causes and possible cures to the immune globulin shortage. Mr. Scheckelhoff provided the perspective of health system pharmacy and commented on the challenges of meeting patient needs during this shortage. ASHP staff provided assistance in his preparation for the hearing.
Witnesses from the federal agencies included Surgeon General David Satcher, MD; FDA Lead Deputy Commissioner Michael Friedman, MD; Stephen M. Ostroff, MD from the Centers for Disease Control and Prevention; and Bernice Steinhardt from the Government Accounting Office.
Private sector witnesses included an immune deficient patient, an immunologist, and representatives from the plasma products industry association as well as individual manufacturers.